Journal of Speech Pathology & Therapy
Open Access

Telepractice; Pediatric Speech-Language Disorders; Speech-Language Pathologists; Remote Assessment; Remote Intervention; Perspectives

Introduction

The landscape of speech-language pathology has evolved significantly with the emergence of telepractice, offering innovative solutions for the assessment and intervention of pediatric speech-language disorders. Telepractice, facilitated by advancements in technology, enables speech-language pathologists (SLPs) to deliver services remotely, transcending geographical barriers and enhancing accessibility to care [1]. This paradigm shift has not only been accelerated by recent global events necessitating remote healthcare delivery but also by the ongoing quest for more flexible and efficient models of service provision. Pediatric speech-language disorders encompass a spectrum of communication challenges, ranging from speech sound disorders and language delays to more complex conditions such as developmental apraxia of speech and autism spectrum disorder. Early identification and intervention are crucial for optimizing outcomes in children with these disorders, underscoring the importance of innovative approaches that can reach children and families wherever they are. The advent of telepractice has revolutionized the field of speech-language pathology, offering new avenues for the assessment and intervention of pediatric speech-language disorders [2-6]. Telepractice, also known as teletherapy or telehealth, involves the use of telecommunications technology to provide speech-language services remotely [7]. This approach has proven particularly valuable in expanding access to care, especially in underserved or rural areas, and has gained significant traction due to its flexibility and convenience [8-10].

The rise of telepractice in speech-language pathology

Telepractice emerged as a viable alternative to traditional in-person services, driven by advancements in technology and the increasing need for accessible healthcare solutions. The COVID-19 pandemic further accelerated its adoption, as social distancing measures and lockdowns necessitated remote healthcare options. For speech-language pathologists (SLPs), telepractice provided a way to continue delivering essential services to children with speech-language disorders without interruption.

Remote assessment of pediatric speech-language disorders

Assessment is a critical component of speech-language pathology, involving the evaluation of a child's speech, language, and communication abilities to identify any disorders or delays. Remote assessment via telepractice employs various digital tools and platforms to conduct evaluations, ensuring that accurate and comprehensive assessments can be performed despite physical distance.

Technological tools and methods

Video Conferencing Platforms: Tools like Zoom, Microsoft Teams, and Doxy.me enable real-time interaction between SLPs and clients, facilitating direct observation and engagement.

Digital Assessment Tools: Standardized tests and informal assessments have been adapted for online use, allowing SLPs to administer evaluations and gather data remotely.

Parental Involvement: Parents or caregivers often play an active role during remote assessments, assisting with activities and providing additional information about the child's communication behaviors in their natural environment.

Therapeutic approaches and techniques

Interactive activities: Games, storytelling, and digital resources are used to make sessions enjoyable and effective.

Parental coaching: SLPs guide parents on how to support their child's communication development at home, ensuring continuity of care outside of scheduled sessions.

Flexible scheduling: Telepractice offers flexibility in scheduling, accommodating the family's routine and reducing the need for travel.

Benefits of remote intervention

Accessibility: Children in remote or underserved areas can receive consistent therapy without geographical barriers.

Convenience: Families save time and resources by eliminating the need for travel, making it easier to integrate therapy into their daily lives.

Continuity of care: Telepractice ensures that therapy can continue uninterrupted during times of crisis, such as during the COVID-19 pandemic.

Insights and perspectives from speech-language pathologists

Speech-language pathologists have shared their insights and experiences regarding the implementation and efficacy of telepractice in pediatric care. Their perspectives highlight both the advantages and challenges of this mode of service delivery.

Positive experiences

Increased Reach: Many SLPs appreciate the ability to reach a wider client base, including those who might not have had access to services otherwise.

Enhanced family involvement: Telepractice often necessitates greater parental involvement, which can lead to better outcomes as parents become more engaged in the therapeutic process.

Flexibility and efficiency: The flexibility of telepractice allows for more efficient scheduling and the ability to conduct sessions from any location.

Challenges Encountered

Technological barriers: Not all families have access to the necessary technology or stable internet connections, which can impede the effectiveness of remote sessions.

Building rapport: Establishing a strong therapeutic relationship can be more challenging in a virtual setting, particularly with younger children who may find it harder to connect through a screen.

Attention and behavior management: Keeping children engaged and managing behaviors remotely requires creative strategies and often additional parental support.

Conclusion

Remote assessment and intervention for pediatric speech-language disorders through telepractice have transformed the field of speech-language pathology. By leveraging technology, SLPs can provide essential services to a broader population, ensuring that children receive the care they need regardless of location. While challenges exist, the benefits of increased accessibility, convenience, and continuity of care make telepractice a valuable tool in the modern healthcare landscape. Insights and experiences from SLPs highlight the potential for telepractice to continue evolving, offering innovative solutions for the assessment and treatment of speech-language disorders in children.

References

1. Dawish MA, Robert AA (2021) COVID-19 in people with diabetes: epidemiologic perspectives and public heth actions in the Middle East and north africa (MENA) region. J Speech Lang Hear Res 17: 1-6.

Indexed at, Google Scholar, Crossref

2. Iacobellis G (2020) COVID-19 and diabetes: can DPP4 inhibition play a role?. J Fluency Disord 162: 108125.

Indexed at, Google Scholar, Crossref

3. Dawish MA (2020) The worrying trend of diabetes mellitus in Saudi Arabia: an urgent cl to action. Curr Diabetes Rev 16: 204-210.

Indexed at, Google Scholar, Crossref

4. Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, et. (2020) COVID-19 in people with diabetes: understanding the reasons for worse outcomes. J Speech Lang Hear Res 8: 782-792.

Indexed at, Google Scholar, Crossref

5. Hayek AA, Robert AA, Matar AB, garni A, kubedan H, et al. (2020) Risk factors for hospit admission among COVID-19 patients with diabetes. Saudi Med J 41: 1090-1097.

Indexed at, Google Scholar, Crossref

6. Robert AA, Dawish MA (2021) COVID-19 in people with diabetes: perspectives from Saudi Arabia. J Fluency Disord 17: 1-6

Indexed at, Google Scholar, Crossref

7. Ahmad A, Atique S, Bkrishnan R, Patel I (2014) Pharmacy profession in India: Currentscenario and Recommendations. Ind J Pharm Edu Res 48:12-15.

Indexed at, Google Scholar, Crossref

8. Travasso C (2016) India draws a red line under antibiotic misuse. Bio Med J 352: i1202.

Indexed at, Google Scholar, Crossref

9. De Matos-Neto EM, Lima JD, de Pereira WO, Figueredo RG, Riccardi DM, et al. (2015) Systemic inflammation in cachexia-is tumor cytokine expression profile the culprit?. Front Immunol 6: 629.

Indexed at, Google Scholar, Crossref

10. Zezza M, Kosinski C, Mekoguem C, Marino L, Chtioui L, et al. (2019) Combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab causing acute-onset type 1 diabetes mellitus following a single administration: two case reports. BMC Endocr Disord 19: 144.

Indexed at, Google Scholar, Crossref